ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本页面由TTMF Limited提供服务
先通醫藥-B
待上市
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
5,904.86萬
香港流通股本:
5,904.86萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
市銷率:
- -
1
开始申购
11/16
2
申購截止
11/19 10:15
3
公布中签
11/20
4
暗盘
11/23 16:15 - 18:30
5
挂牌上市
11/24
總覽
公司
新聞資訊
公告
公司資料
公司名字:
先通醫藥-B
交易所:
SEHK
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
https://www.sinotau.com/
郵編:
- -
電話:
- -
傳真:
- -
簡介:
先通醫藥專註於創新放射性藥物的研發及商業化,布局神經、心血管和腫瘤疾病領域,開發用於精準診斷和靶向治療的放射性藥物。公司總部位於北京,在上海設有研發中心,在江蘇、廣東和四川建設放射性藥物生產基地,並在美國設有分支機構。
董事
名稱
職位
徐新盛
董事會主席,執行董事,戰略委員會主席,提名委員會主席
唐艷旻
執行董事,薪酬與考核委員會委員
王鵬
執行董事
儲維
執行董事
虞文彬
執行董事
陳道金
非執行董事
張英傑
非執行董事
葉索夫
非執行董事
黃序
非執行董事
郝伯男
非執行董事
倪虹
獨立非執行董事,薪酬與考核委員會委員,審計委員會主席
Jimmy Zhimin ZHANG
獨立非執行董事,提名委員會委員,審計委員會委員
吳海東
獨立非執行董事,戰略委員會委員
楊悅
獨立非執行董事,薪酬與考核委員會主席,提名委員會委員
康彩練
獨立非執行董事,戰略委員會委員,審計委員會委員
股東
名稱
職位
徐新盛
總經理
儲維
副總裁
劉爽
副總經理
金贇
副總經理
虞文彬
首席財務官,董事會秘書,聯席公司秘書
湯家錡
聯席公司秘書
唐艷旻
聯席首席執行官
王鵬
聯席首席執行官
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hant/stock/09941/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09941","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09941\",,,,,undefined,":{"symbol":"09941","market":"HK","secType":"STK","nameCN":"先通醫藥-B","latestPrice":0,"timestamp":1794816000000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":59048600,"shares":59048600,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"11-16 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1795483800000},"marketStatusCode":8,"adr":0,"listingDate":1795449600000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1794792600000,1794801600000],[1794805200000,1794816000000]],"volumeRatio":0,"ipoDetail":{"name":"先通医药-B","exchange":"SEHK","listingDate":"2026-11-24","sharesOutstanding":65609614,"sharesFloat":65609614,"offerAmount":6561000,"priceRange":"52.00 - 68.00","market":"HK","openProspectusDate":"2026-11-16","openProspectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/09941/2026/2026111600012_c.pdf","purchaseBeginDate":"2026-11-16","purchaseEndDate":"2026-11-19","winningDate":"2026-11-23","currency":"HKD","minPurchaseQuantity":50,"peRate":-5.83,"use":"1、88.0%(约289.5百万港元)将用于核心产品的研发及注册申报;\n2、4.9%(约16.1百万港元)将用于其他候选产品的研发;\n3、1.1%(约3.5百万港元)将用于加强销售及营销能力;\n4、1.0%(约3.5百万港元)将用于在天津建设新生产基地;\n5、5.0%(约16.5百万港元)将用作营运资金及其他一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司致力于开发及商业化具有可观市场潜力的诊断及治疗放射性药物,根据灼识咨询报告,公司是中国首家(i)获得创新放射性药物上市批准的企业;(ii)以MAH身份获得创新放射性药物生产许可的企业;及(iii)完成治疗用放射性配体注册临床试验并获国家药监局受理NDA的企业。","subscribed":52.57,"marketCap":3411999999.9999995,"minimumCapital":3434.29,"overAllotment":true,"lotSize":50,"issueOpenRate":0.1,"subscribeGear":"50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,125000,150000,175000,200000,225000,250000,275000,300000,328050","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-11-23","greyDateTimestamp":1795363200000,"greyOpeningTime":1795421700000,"greyClosingTime":1795429800000,"showGreyQuote":false,"openProspectusDate":"2026-11-16","listingDate":"2026-11-24"},"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09941\",,,,,undefined,":{"symbol":"09941","floatShares":59048600,"roa":"--","roe":"--","lyrEps":0,"shares":59048600,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/09941\",,undefined,":{"id":10911,"type":"COMMON","ipoName":"09941-IPO","symbol":"09941","companyName":"先通醫藥-B","market":"HK","currency":"HKD","status":"OPEN","underwriter":"廣發融資(香港)有限公司","lotSize":50,"minQty":50,"expectedOfferingSize":6561000,"openingDate":1794792600000,"closingDate":1795054500000,"commonClosingDate":1795054500000,"allotmentDate":1795104000000,"listDate":1795449600000,"marginable":true,"marginRate":10,"latestPrice":68,"minPrice":52,"maxPrice":68,"prospectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/09941/2026/2026111600012_c.pdf","allowedQuantities":[50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,125000,150000,175000,200000,225000,250000,275000,300000,328050],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1795017600000,"interestEndDate":1795017600000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1795421700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"09941-IPO","ipoId":10911,"financingId":64083,"type":1,"availableFundLimit":3434.28,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":34342.8,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1794792600000,"closeTime":1795054500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":3434.28,"threshold":50000000000,"isAvailable":false},{"ipoName":"09941-IPO","ipoId":10911,"financingId":64069,"type":4,"availableFundLimit":3434.28,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1794792600000,"closeTime":1795054500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":3434.28,"threshold":20000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"FINANCING","closeTime":1795054500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":3434.28},{"method":"CASH","closeTime":1795054500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":3434.28}],"latestClosingDate":1795054500000,"subscribedFinanceRatio":52.57,"subscribedRatio":52.57,"forecastRatio":74.13,"raiseMoney":44610000,"totalMargin":2345750000,"quoteInfoUpdatedAt":1794843062709,"prospectusUpdatedAt":1794798846000,"forecastMarketValue":3936576840,"minForecastMarketValue":3411699928,"maxForecastMarketValue":4461453752,"sharesOutstanding":65609614,"business":"公司致力於開發及商業化具有可觀市場潛力的診斷及治療放射性藥物,根據灼識諮詢報告,公司是中國首家(i)獲得創新放射性藥物上市批準的企業;(ii)以MAH身份獲得創新放射性藥物生產許可的企業;及(iii)完成治療用放射性配體註冊臨床試驗並獲國家藥監局受理NDA的企業。","greyOpeningTime":1795421700000,"greyClosingTime":1795429800000,"tradable":true,"showClawback":true,"clawbackType":"機制B","clawbackRate":10},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"https://www.sinotau.com/","compareEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0278},{"period":"3month","weight":-0.0589},{"period":"6month","weight":-0.0896},{"period":"1year","weight":-0.1269},{"period":"ytd","weight":-0.0778}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"先通醫藥專註於創新放射性藥物的研發及商業化,布局神經、心血管和腫瘤疾病領域,開發用於精準診斷和靶向治療的放射性藥物。公司總部位於北京,在上海設有研發中心,在江蘇、廣東和四川建設放射性藥物生產基地,並在美國設有分支機構。","exchange":"SEHK","name":"先通醫藥-B","nameEN":"SINOTAUPHARMA-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"09941\",market:\"HK\",,,undefined,":{"directors":[{"name":"徐新盛","position":"董事會主席,執行董事,戰略委員會主席,提名委員會主席"},{"name":"唐艷旻","position":"執行董事,薪酬與考核委員會委員"},{"name":"王鵬","position":"執行董事"},{"name":"儲維","position":"執行董事"},{"name":"虞文彬","position":"執行董事"},{"name":"陳道金","position":"非執行董事"},{"name":"張英傑","position":"非執行董事"},{"name":"葉索夫","position":"非執行董事"},{"name":"黃序","position":"非執行董事"},{"name":"郝伯男","position":"非執行董事"},{"name":"倪虹","position":"獨立非執行董事,薪酬與考核委員會委員,審計委員會主席"},{"name":"Jimmy Zhimin ZHANG","position":"獨立非執行董事,提名委員會委員,審計委員會委員"},{"name":"吳海東","position":"獨立非執行董事,戰略委員會委員"},{"name":"楊悅","position":"獨立非執行董事,薪酬與考核委員會主席,提名委員會委員"},{"name":"康彩練","position":"獨立非執行董事,戰略委員會委員,審計委員會委員"}],"executives":[{"name":"徐新盛","position":"總經理"},{"name":"儲維","position":"副總裁"},{"name":"劉爽","position":"副總經理"},{"name":"金贇","position":"副總經理"},{"name":"虞文彬","position":"首席財務官,董事會秘書,聯席公司秘書"},{"name":"湯家錡","position":"聯席公司秘書"},{"name":"唐艷旻","position":"聯席首席執行官"},{"name":"王鵬","position":"聯席首席執行官"}]}}}